ALX Oncology Holdings Inc.
USD2.13
-0.07 (-2.95%)
CEO
Jason Lettmann
IPO Date
2020-07-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.20
Prev. Close
$2.20
Day Low
$2.12
Day High
$2.22
52W Low
$0.41
52W High
$2.66
Market Cap
$0.29B
Volume
0.35M
| -0.6 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -84.8% | -66.3% | 0.09 | 5.24 | -4.0 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -46.9% | -40.3% | 0.04 | 9.57 | -3.7 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -23.0% | -22.0% | 0.00 | 24.00 | -10.4 |
| 31 Dec 2020 | FY | 9.1% | -3869.7% | -10.6% | -10.5% | 0.00 | 70.28 | -75.1 |
| 31 Dec 2019 | FY | 9.1% | -401.2% | 6972.1% | -180.2% | -19.64 | 1.97 | -34.2 |
| 31 Dec 2018 | FY | 9.0% | -664.3% | -150.0% | -123.0% | 0.00 | 5.45 | -48.0 |
| -0.7 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -49.4% | -26.8% | 0.10 | 2.40 | -1.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -40.3% | -27.2% | 0.25 | 4.52 | -0.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -34.8% | -25.4% | 0.11 | 5.47 | -0.3 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -25.7% | -19.7% | 0.09 | 7.26 | -0.8 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -22.4% | -16.5% | 0.07 | 4.82 | -0.8 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -24.7% | -18.4% | 0.11 | 4.39 | -2.0 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -21.7% | -16.7% | 0.10 | 5.21 | -3.9 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -24.0% | -18.7% | 0.09 | 5.24 | -4.0 |